Last reviewed · How we verify

NCT06174610

Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.

Recruiting now Last updated 3 June 2025
What this trial tests

trial testing Measurement of Renal Resistive Index in Acute Kidney Injury in 50 participants. Currently enrolling.

Timeline
19 December 2023
Primary endpoint
21 May 2026
18 December 2026

Quick facts

Lead sponsorUniwersytecki Szpital Kliniczny w Opolu
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date19 December 2023
Primary completion21 May 2026
Estimated completion18 December 2026
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Uniwersytecki Szpital Kliniczny w Opolu — full company profile →

Who can join

18 and older, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to determine whether there is a correlation between changes in the renal resistive index and the restoration of kidney function in critically ill patients undergoing continuous renal replacement therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

Other Uniwersytecki Szpital Kliniczny w Opolu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06174610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing